DarioHealth (DRIO) Scheduled to Post Quarterly Earnings on Wednesday

DarioHealth (NASDAQ:DRIO) will issue its quarterly earnings data before the market opens on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.59) per share for the quarter.

DarioHealth (NASDAQ:DRIO) last released its earnings results on Thursday, March 28th. The company reported ($0.41) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.54) by $0.13. The firm had revenue of $3.62 million during the quarter, compared to the consensus estimate of $3.57 million. DarioHealth had a negative net margin of 165.96% and a negative return on equity of 48.84%. On average, analysts expect DarioHealth to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

DarioHealth Trading Down 1.2 %

NASDAQ:DRIO opened at $1.61 on Wednesday. DarioHealth has a 12 month low of $0.68 and a 12 month high of $4.58. The company has a current ratio of 3.79, a quick ratio of 3.38 and a debt-to-equity ratio of 0.42. The firm’s 50 day moving average is $1.50 and its 200 day moving average is $1.64. The stock has a market capitalization of $47.77 million, a PE ratio of -1.58 and a beta of 1.64.

Analyst Ratings Changes

Separately, Stifel Nicolaus reiterated a “buy” rating and set a $4.00 target price on shares of DarioHealth in a research report on Monday, April 1st.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.